Association of
MGMT
Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide
JAMA Oncology | June 28, 2018 | Volume: 4 | Issue: 10 | Pages: 1405
10.1001/jamaoncol.2018.1977
| PMID 29955793